Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer

Sewha Kim, Do Hee Kim, Woo Hee Jung, Ja Seung Koo

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The aim of this study was to investigate the expression of glutamine metabolism-related proteins to determine whether glutamine is metabolized differently according to breast cancer molecular subtype. We generated a tissue microarray of 702 breast cancer patients and performed immunohistochemical staining for glutamine metabolism-related proteins, including glutaminase 1 (GLS1 (GLS)), glutamate dehydrogenase (GDH (H6PD)), and amino acid transporter-2 (ASCT2 (SLC1A5)), which were separately evaluated in tumor and stroma compartments and then analyzed by breast cancer molecular subtypes. Breast cancers were classified as follows: 293 luminal A (41.7%), 166 luminal B (23.6%), 67 HER2 type (9.6%), and 176 TNBC (25.1%). HER2 type showed the highest stromal GLS1 (P=0.001), tumoral GDH (P=0.001), stromal GDH (P<0.001), and tumoral ASCT (P<0.001) expression. We identified differential expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. The highest glutamine metabolic activity was seen in HER2-type breast cancer.

Original languageEnglish
Pages (from-to)339-348
Number of pages10
JournalEndocrine-Related Cancer
Volume20
Issue number3
DOIs
Publication statusPublished - 2013 Jun 1

Fingerprint

Glutamine
Breast Neoplasms
Proteins
Glutaminase
Amino Acid Transport Systems
Glutamate Dehydrogenase
Staining and Labeling
Neoplasms

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Endocrinology
  • Cancer Research

Cite this

@article{0510d201dbc44f039b23f2e928ea9c46,
title = "Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer",
abstract = "The aim of this study was to investigate the expression of glutamine metabolism-related proteins to determine whether glutamine is metabolized differently according to breast cancer molecular subtype. We generated a tissue microarray of 702 breast cancer patients and performed immunohistochemical staining for glutamine metabolism-related proteins, including glutaminase 1 (GLS1 (GLS)), glutamate dehydrogenase (GDH (H6PD)), and amino acid transporter-2 (ASCT2 (SLC1A5)), which were separately evaluated in tumor and stroma compartments and then analyzed by breast cancer molecular subtypes. Breast cancers were classified as follows: 293 luminal A (41.7{\%}), 166 luminal B (23.6{\%}), 67 HER2 type (9.6{\%}), and 176 TNBC (25.1{\%}). HER2 type showed the highest stromal GLS1 (P=0.001), tumoral GDH (P=0.001), stromal GDH (P<0.001), and tumoral ASCT (P<0.001) expression. We identified differential expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. The highest glutamine metabolic activity was seen in HER2-type breast cancer.",
author = "Sewha Kim and Kim, {Do Hee} and Jung, {Woo Hee} and Koo, {Ja Seung}",
year = "2013",
month = "6",
day = "1",
doi = "10.1530/ERC-12-0398",
language = "English",
volume = "20",
pages = "339--348",
journal = "Endocrine-Related Cancer",
issn = "1351-0088",
publisher = "Society for Endocrinology",
number = "3",

}

Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. / Kim, Sewha; Kim, Do Hee; Jung, Woo Hee; Koo, Ja Seung.

In: Endocrine-Related Cancer, Vol. 20, No. 3, 01.06.2013, p. 339-348.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer

AU - Kim, Sewha

AU - Kim, Do Hee

AU - Jung, Woo Hee

AU - Koo, Ja Seung

PY - 2013/6/1

Y1 - 2013/6/1

N2 - The aim of this study was to investigate the expression of glutamine metabolism-related proteins to determine whether glutamine is metabolized differently according to breast cancer molecular subtype. We generated a tissue microarray of 702 breast cancer patients and performed immunohistochemical staining for glutamine metabolism-related proteins, including glutaminase 1 (GLS1 (GLS)), glutamate dehydrogenase (GDH (H6PD)), and amino acid transporter-2 (ASCT2 (SLC1A5)), which were separately evaluated in tumor and stroma compartments and then analyzed by breast cancer molecular subtypes. Breast cancers were classified as follows: 293 luminal A (41.7%), 166 luminal B (23.6%), 67 HER2 type (9.6%), and 176 TNBC (25.1%). HER2 type showed the highest stromal GLS1 (P=0.001), tumoral GDH (P=0.001), stromal GDH (P<0.001), and tumoral ASCT (P<0.001) expression. We identified differential expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. The highest glutamine metabolic activity was seen in HER2-type breast cancer.

AB - The aim of this study was to investigate the expression of glutamine metabolism-related proteins to determine whether glutamine is metabolized differently according to breast cancer molecular subtype. We generated a tissue microarray of 702 breast cancer patients and performed immunohistochemical staining for glutamine metabolism-related proteins, including glutaminase 1 (GLS1 (GLS)), glutamate dehydrogenase (GDH (H6PD)), and amino acid transporter-2 (ASCT2 (SLC1A5)), which were separately evaluated in tumor and stroma compartments and then analyzed by breast cancer molecular subtypes. Breast cancers were classified as follows: 293 luminal A (41.7%), 166 luminal B (23.6%), 67 HER2 type (9.6%), and 176 TNBC (25.1%). HER2 type showed the highest stromal GLS1 (P=0.001), tumoral GDH (P=0.001), stromal GDH (P<0.001), and tumoral ASCT (P<0.001) expression. We identified differential expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. The highest glutamine metabolic activity was seen in HER2-type breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84879491733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879491733&partnerID=8YFLogxK

U2 - 10.1530/ERC-12-0398

DO - 10.1530/ERC-12-0398

M3 - Article

C2 - 23507704

AN - SCOPUS:84879491733

VL - 20

SP - 339

EP - 348

JO - Endocrine-Related Cancer

JF - Endocrine-Related Cancer

SN - 1351-0088

IS - 3

ER -